Arena Pharmaceuticals Inc.
Rank 4
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
$45.1600
USD
2.50%
Market cap
$2,250,104,315
Total volume
$30,493,522
Shares outstanding
49,825,162
Rank 4
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
ARNA |
$30,493,522
|
100% |
$45.1600
|
Chart